- 全部删除
- 您的购物车当前为空
Selective μ opioid receptor agonist (IC50 values are 5.5 and > 10000 nM for inhibition of 125I-FK 33,824 and 125I-DADLE binding to μ and δ sites respectively). Produces naloxone-reversible analgesia, catalepsy and hyperthermia following central administration in rats in vivo.
Selective μ opioid receptor agonist (IC50 values are 5.5 and > 10000 nM for inhibition of 125I-FK 33,824 and 125I-DADLE binding to μ and δ sites respectively). Produces naloxone-reversible analgesia, catalepsy and hyperthermia following central administration in rats in vivo.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥ 1,917 | 待询 |
PL-017 相关产品
产品描述 | Selective μ opioid receptor agonist (IC50 values are 5.5 and > 10000 nM for inhibition of 125I-FK 33,824 and 125I-DADLE binding to μ and δ sites respectively). Produces naloxone-reversible analgesia, catalepsy and hyperthermia following central administration in rats in vivo. |
别名 | PL 017 |
分子量 | 535.64 |
分子式 | C29H37N5O5 |
CAS No. | 83397-56-2 |
密度 | 1.313g/cm3 |
Sequence Short | YP-{N(Me)Phe}-P-NH2 |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
溶解度信息 | H2O: 1 mg/mL (1.87 mM), Sonication is recommended. | ||||||||||
溶液配制表 | |||||||||||
H2O
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容